Please try another search
TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.
Name | Age | Since | Title |
---|---|---|---|
Steven C. Katz | 49 | 2018 | Chief Medical Officer & Chairman of Scientific Advisory Board |
Vincent J. Picozzi | - | - | Member of Scientific Advisory Board |
Terence Gade | - | - | Member of Scientific Advisory Board |
Ripal T. Gandhi | - | - | Member of Scientific Advisory Board |
David J. Matlin | 62 | 2023 | Independent Director |
Mary T. Szela | 60 | 2018 | CEO, President & Director |
Sean Edward Murphy | 71 | 2021 | CFO & Director |
Richard D. Carvajal | - | - | Member of Scientific Advisory Board |
Alexander Y. Kim | - | - | Member of Scientific Advisory Board |
Sirish Kishore | - | - | Member of Scientific Advisory Board |
Rahul Sheth | - | - | Member of Scientific Advisory Board |
Christopher Crane | - | - | Member of Scientific Advisory Board |
Mats L. Wahlstrom | 70 | 2016 | Independent Chairman |
Michael Pishvaian | - | 2022 | Scientific Advisory Board Member |
Andrew C. von Eschenbach | 82 | 2023 | Independent Director |
George Kelly Martin | 65 | 2023 | Independent Director |
Arjun M. Desai | 42 | 2023 | Independent Director |
Anil Singhal | 72 | 2023 | Independent Director |
Jordan C. Tasse | - | 2022 | Member of Scientific Advisory Board |
Sapna Patel | - | - | Member of Scientific Advisory Board |
Marlana M. Orloff | - | - | Member of Scientific Advisory Board |
Kerry R. Hicks | 64 | 2023 | Independent Director |
Divya Sridhar | - | 2022 | Member of Scientific Advisory Board |
Venu G. Pillarisetty | - | 2022 | Member of Scientific Advisory Board |
Liselotte Hyveled | 58 | 2024 | Non-Employee Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review